RLAY — Relay Therapeutics Share News
0.000.00%
Last trade - 00:00- $3.79bn
- $2.88bn
- $15.36m
Brief: Relay Therapeutics Q1 Net Income USD -73.291 Million Vs. IBES Estimate USD -65 Million
U.S. RESEARCH ROUNDUP-Commvault Systems, Domino's Pizza, Organon & Co
Relay Therapeutics beats Q4 revenue expectations
Brief: Relay Therapeutics Q4 Net Income USD -54.889 Million Vs. IBES Estimate USD -68.1 Million
Brief: Relay Therapeutics Announces Zovegalisib Granted Therapy Designation By FDA For Pik3ca-Mutant
Advisory: Alert from Equity-Insider.com was published in error and has been withdrawn
Relay Therapeutics slightly misses Q3 net loss estimates, expects cash reserves to fund operations into 2029
Brief: Relay Therapeutics Q3 Net Income USD -74.149 Million Vs. IBES Estimate USD -73.9 Million
Relay Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Relay Therapeutics Q2 Net Income USD -70.375 Million
Relay Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview
Brief: Relay Therapeutics Appoints Claire Mazumdar To Board Of Directors
Relay Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Relay Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Autodesk, Coca-Cola, NetApp
Relay Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Relay Therapeutics Q4 Net Income USD -76.004 Million
Relay Therapeutics Inc expected to post a loss of 56 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Gold miners, Tesla, ADM